Trial intelligence / Profile preview

Clindamycin/Tretinoin Gel for Rosacea

NCT00823901Phase 3Completed

Sponsor
Massachusetts General Hospital
Start
Feb 2009
Primary completion
Oct 2010
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of clindamycin, tretinoin in papulopustular rosacea, sponsored by Massachusetts General Hospital. Started Feb 2009; status: completed.

02

Drugs

clindamycintretinoin
03

Conditions

papulopustular rosacea

Beyond the preview

Go deeper on NCT00823901.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00823901.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call